EXIT READINESS SPRINT™

Clarify the story buyers need to believe — before valuation pressure hits

Schedule a Strategic Fit Call

The Exit Readiness Sprint is a 90-day engagement that helps leadership teams growth story clear, aligned, and ready for scrutiny. Buyers, investors, and partners will immediately understand what makes the business valuable.

We help leadership teams clearly articulate what makes their business valuable, in language buyers, investors, and partners immediately understand. The result is a growth story that travels beyond the founder, holds up under scrutiny, and supports stronger outcomes when pressure shows up. This is about making the value you’ve already built obvious to the people who decide what it’s worth.

Dashboard mockup

Who this is for

The Exit Readiness Sprint is built for healthtech and pharmacy leaders who recognize one or more of these situations:
Buyers or partners don’t quickly grasp what truly makes the business valuable
Messaging feels inconsistent after growth, acquisitions, or product changes
The external story no longer reflects the strength of what you’ve built internally
Performance is solid, but the story isn’t helping you in critical conversations
You don’t have a weak business. You have a commercial clarity gap. And buyers notice it earlier than most teams expect.

Why this matters more than most teams realize

Strong revenue and EBITDA do not automatically translate into strong evaluation.
Long before diligence begins, buyers form conviction based on how clearly they understand:
What actually drives growth
Why customers choose you and stay
Whether value depends on the founder or transfers
to the business
When the story is unclear, fragmented, or founder-dependent, deals slow down, confidence erodes, and valuation suffers — even when performance is strong.

The Exit Readiness Sprint addresses this risk before it shows up in pricing, terms, or deal friction.
Schedule a Strategic Fit Call
WHAT OUR CLIENTS SAY
“Before the Exit Readiness Sprint, I didn't have an appreciation for what a successful external engagement could bring to the business. The work that Legacy DNA has done over the last 3 months will drive more value than I was ever expecting going into the engagement. I will make the decision to use Legacy DNA time and time again regardless of where my career takes me.”
— Natasha Hennessy, CEO of Apotheco Medicinals

What changes in 90 days

By the end of the Exit Readiness Sprint™, you’ll have a clear, aligned growth story your leadership team can stand behind, and buyers can understand, trust, and defend.

You’ll leave with:
01

CUSTOMER PERSONA PACK

Clear, buyer-relevant personas tied to motivations, adoption barriers, and value drivers
02

CORE MESSAGING FAMEWORK

Clear, buyer-relevant personas tied to motivations, adoption barriers, and value drivers
03

POSITIONING BLUEPRINT

A differentiated market position grounded in proof, traction, and competitive context
04

CORPORATE NARRATIVE ARCHITECTURE

A unified growth story that connects vision, impact, and value creation
05

MARKET GROWTH DECK

A practical for customer conversations today and buyer diligence tomorrow
06

NEXT-STEP PLAN

Clear priorities to maintain momentum and strengthen buyer confidence beyond the sprint

HOW THE SPRINT WORKS

Designed for buyer scrutiny

The Exit Readiness Sprint follows a structured process designed to stand up to buyer, board, and diligence scrutiny.

Phase 1:

Assessment & Alignment

Identify narrative gaps, valuation risk, and leadership misalignment early

Phase 2:

Define Customers & Value

Clarify who drives growth and why customers choose you

Phase 3:

Shape the Story

Bring proof, differentiation, and growth drivers into one clear narrative

Phase 4:

Package for Use

Turn the story into tools leaders, buyers, and partners can rely on

Why this works

Many companies lose value because the story doesn’t travel.

The Exit Readiness Sprint works because it’s:
Built through a BUYER lens.
Designed around how buyers evaluate risk, growth, and transferability, not how teams like to describe themselves.
Focused on TRANSFERABILITY, not founders.
Ensures value is clearly
understood beyond any
one individual.
Grounded in PROOF, not positioning statements.
Aligns narrative to real
traction, outcomes, and
market context.
Designed to REDUCE valuation risk early.
Addresses clarity gaps
before diligence or deal
pressure exposes them.

How this fits with the other
Legacy DNA paths

Different stages require different leverage.
“We need
clarity before
pressure hits.”
“Buyers aren’t
seeing our
full value.”
“We need
predictable,
scalable
enterprise value.”
Not sure where you fit? Start with the Exit Readiness Scorecard →

Why Legacy DNA?

We specialize in commercialization as a valuation lever,
not a marketing exercise.

Our work is grounded in doctoral-level rigor and real-world execution, shaped by Dr. Roxie Mooney’s research and experience commercializing healthcare and technology innovation. That foundation informs how Legacy DNA approaches clarity, risk reduction, and value creation, and how our team delivers work that holds up under buyer scrutiny.

Every engagement is senior-led and standards-driven, designed to perform where it matters most: boardrooms, IC meetings, and diligence conversations. We combine deep healthcare commercialization expertise with a clear understanding of buyer psychology, regulatory complexity, and enterprise value creation.

We've helped leadership teams navigate four Successful exits by turning strong businesses into stories buyers recognize, trust, and value.

Your Next Step

Schedule Your
Strategic Fit Call

It’s a practical conversation to determine whether the Exit
Readiness Sprint fits your situation and what will actually
best serve your goals.

No pitch. No pressure. Just clarity.

Book my Strategic Fit Call